Farther Finance Advisors, LLC Karuna Therapeutics, Inc. Transaction History

Farther Finance Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.0 - $329.83 $0 - $989	-3 Closed	0 $0
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $1,288 - $2,542	-8 Reduced 61.54%	5 $1.58 Million
Q3 2023 Nov 13, 2023	BUY	$164.66 - $218.08 $1,646 - $2,180	10 Added 333.33%	13 $2.2 Million
Q2 2023 May 13, 2024	BUY	$176.32 - $240.22 $176 - $240	1 Added 50.0%	3 $651,000
Q2 2023 Sep 12, 2023	BUY	$176.32 - $240.22 $176 - $240	1 Added 50.0%	3 $651,000
Q1 2023 May 13, 2024	SELL	$161.33 - $204.36 $483 - $613	-3 Reduced 60.0%	2 $363,000
Q4 2022 Sep 11, 2023	BUY	$191.53 - $236.82 $383 - $473	2 New	2 $393,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Farther Finance Advisors, LLC with notifications on news.